What three items must a trading partner confirm they have received before distributing a prescription drug?

The correct choice is based on the requirements set forth by federal regulations pertaining to traceability of prescription drugs throughout the supply chain. A trading partner must confirm receipt of transaction information, transaction history, and a transaction statement before distributing a prescription drug.

Transaction information includes specifics about the drug, such as the product identifiers, transaction details, and the parties involved in the transaction. Transaction history refers to an unbroken chain of documents that track the drug’s movement from the manufacturer to the wholesaler and then to the pharmacy or retailer. The transaction statement is a declaration by the seller that outlines the chain of ownership and confirms that the drugs being transferred are legitimate and have not been stolen or counterfeit.

These three items are essential for compliance with the Drug Supply Chain Security Act (DSCSA), which aims to secure the supply chain for prescription medications and minimize the risk of counterfeit drugs. The other options do not align with the specific compliance requirements under DSCSA and focus instead on unrelated documentation or details that do not fulfill the obligation of a trading partner in the distribution of prescription drugs.